1 Migita K, Sasaki Y, Ishizuka N, Arai T, Kiyokawa T,
Suematsu E, et al. Glucocorticoid Therapy and the Risk of
Infection in Patients With Newly Diagnosed Autoimmune
Disease. Medicine (Baltimore). 2013;92:285-93. DOI: 10.1097/
MD.0b013e3182a72299, PMID: 23982055
2 Team NGU. National Institute for Health and Care Excellence: Clinical Guidelines. Ulcerative colitis: management
[Internet]. London: National Institute for Health and Care
Excellence (UK); 2019 [cited 2020 Nov 3]. Available from:
http://www.nice.org.uk/guidance/ng130.
3 Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR,
Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients with inflammatory bowel
disease. Gastroenterology. 2008;134:929-36. DOI: 10.1053/
j.gastro.2008.01.012, PMID: 18294633
4 Borchard NA, Nayak JV. Orbital Apex Syndrome. N Engl J
Med. 2018;378:e23. DOI: 10.1056/NEJMicm1703770, PMID:
29694826
5 Thurtell MJ, Chiu ALS, Goold LA, Akdal G, Crompton JL,
Ahmed R, et al. Neuro-ophthalmology of invasive fungal
sinusitis: 14 consecutive patients and a review of the literature. Clin Exp Ophthalmol. 2013;41:567-76. DOI: 10.1111/
ceo.12055, PMID: 23279383
6 Siddiqui AA, Shah AA, Bashir SH. Craniocerebral aspergillosis of sinonasal origin in immunocompetent patients:
clinical spectrum and outcome in 25 cases. Neurosurgery.
2004;55:602-13. DOI: 10.1227/01.NEU.0000134597.94269.48,
PMID: 15335427
7 Masuda H, Takahashi Y, Nishida Y, Asai S. Comparison
of the effect of mesalazine and sulfasalazine on laboratory
parameters: a retrospective observational study. Eur J Clin
Pharmacol. 2012;68:1549-55. DOI: 10.1007/s00228-012-12893, PMID: 22546896
8 Verspaget HW, Aparicio-Pagés MN, Verver S, Edelbroek
PM, Haf kenscheid JCM, Crama-bohbouth GE, et al.
Influence of sulphasalazine and mesalazine on cellular and
biochemical oxygen metabolite production. Effect of in vivo
administration and an in vitro analysis. Scand J Gastroenterol.
1991;26:779-86. DOI: 10.3109/00365529108998599, PMID:
1680247
9 Chawdhary G, Hussain S, Corbridge R. Delayed diagnosis of
central skull-base osteomyelitis with abscess: case report and
learning points. Ann R Coll Surg Engl. 2017;99:e24-7. DOI:
10.1308/rcsann.2016.0283, PMID: 27659382
10 Fernandes YB, Ramina R, Borges G, Queiroz LS, Maldaun
MVC, Maciel JA Jr. Orbital apex syndrome due to aspergillosis: case report. Arq Neuropsiquiatr. 2001;59:806-8. DOI:
10.1590/S0004-282X2001000500029, PMID: 11593288
11 Hosseini SMS, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol.
2005;262:932-8. DOI: 10.1007/s00405-005-0919-0, PMID:
15891927
12 Swift AC, Denning DW. Skull base osteitis following fungal
sinusitis. J Laryngol Otol. 1998;112:92-7. DOI: 10.1017/
S0022215100140009, PMID: 9538458
13 Middelhof CA, Loudon WG, Muhonen MD, Xavier C,
Greene CS Jr. Improved survival in central nervous system
aspergillosis: a series of immunocompromised children with
leukemia undergoing stereotactic resection of aspergillomas.
Report of four cases. J Neurosurg. 2005;103(suppl):374-8.
DOI: 10.3171/ped.2005.103.4.0374, PMID: 16270691
14 Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R,
Kontoyiannis DP, Marr KA, et al.; Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice
guidelines of the Infectious Diseases Society of America. Clin
Infect Dis. 2008;46:327-60. DOI: 10.1086/525258, PMID:
18177225
15 Arakawa H, Suto C, Notani H, Ishida T, Abe K, Ookubo Y.
Selection of the antifungal agent decides prognosis of invasive
aspergillosis: case report of a successful outcome with voriconazole. Int Ophthalmol. 2014;34:85-9. DOI: 10.1007/s10792013-9730-x, PMID: 23397120
213
© 2021 Tottori University Medical Press
...
論文の公開元へ
